Outcome of idiopathic restrictive cardiomyopathy in children

Rachel J Weller1, Robert Weintraub, Linda J Addonizio

  • 1Division of Pediatric Cardiology, Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Insights

Idiopathic restrictive cardiomyopathy (IRC) in children often leads to pulmonary hypertension, a predictor of poor outcomes. Early monitoring of pulmonary vascular resistance index (PVRI) is crucial for timely cardiac transplant evaluation.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Pulmonology

Background:

  • Idiopathic restrictive cardiomyopathy (IRC) is a rare condition in children.
  • Identifying predictors of poor outcomes in pediatric IRC is essential for management.

Purpose of the Study:

  • To identify potential predictors of poor outcomes in children with idiopathic restrictive cardiomyopathy (IRC).
  • To investigate the role of pulmonary hypertension in the prognosis of pediatric IRC.

Main Methods:

  • Retrospective study of 18 children diagnosed with idiopathic restrictive cardiomyopathy (IRC).
  • Analysis of clinical presentation, cardiac output (CO) syndrome development, hemodynamic parameters including pulmonary vascular resistance index (PVRI), and outcomes.
  • Comparison of PVRI in IRC patients with those of children with dilated cardiomyopathy referred for heart transplant.

Main Results:

  • Four patients presented with low cardiac output (CO) syndrome; 14 developed it later.
  • Elevated pulmonary vascular resistance index (PVRI >6 U-m(2)) was observed in 10 of 18 patients and was associated with death (p <0.01).
  • Severe pulmonary hypertension precluded 40% of eligible patients from cardiac transplantation.

Conclusions:

  • Elevated PVRI is a significant predictor of poor outcomes and mortality in pediatric idiopathic restrictive cardiomyopathy (IRC).
  • Pulmonary hypertension can be a contraindication for cardiac transplantation in children with IRC.
  • Serial monitoring of PVRI in children with IRC is recommended to guide timely transplant evaluation.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...